Literature DB >> 16554221

Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles.

Michael Alexander McDonald1, Kenneth L Watkin.   

Abstract

RATIONALE AND
OBJECTIVES: Relatively few studies involving the physicochemical properties of crystalline, nanometer-sized particulate gadolinium complexes have been reported. This is in part because of the challenges associated with making nanoparticulate gadolinium suspensions that are stable in aqueous solution. Small particulate gadolinium oxide (SPGO) and SPGO embedded in albumin microspheres (gadolinium oxide albumin microspheres, GOAM), have been used experimentally as prototype contrast agents for multimodality imaging.
MATERIALS AND METHODS: In the present study, an initial attempt was made to better solubilize SPGO, prevent particle aggregation, and investigate the physicochemical properties of dextran SPGO relevant to its use as a high-field magnetic resonance contrast agent in aqueous solution.
RESULTS: Dextran SPGO demonstrates regular crystalline lattices and has a gadolinium oxide electron diffraction pattern consistent with that of published X-ray powder diffraction (XPD) patterns. The subtraction XPD pattern of dextran SPGO shows diffraction angles and intensities similar, but not identical, to that of published Gd2O3 diffraction patterns. High r2/r1 ratios and magnetic susceptibility studies indicate dextran SPGO can be classified as a superparamagnetic compound. Enhanced relaxivity is observed at high magnetic field strength; largely because of solubilization of SPGO via the surface adherent carbohydrate. Perhaps also contributing to the observed relaxivity enhancement is the ideal lattice structure of the central gadolinium oxide crystal and the effects of sonochemical preparation on nanoparticle physicochemical properties.
CONCLUSIONS: It is anticipated that these studies will help provide a basis for the development of novel nanoparticulate contrast agent platforms capable of improving T1 and T2/T2* contrast for high-field magnetic resonance imaging and molecular imaging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554221     DOI: 10.1016/j.acra.2005.11.005

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  16 in total

1.  Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Authors:  He Wei; Oliver T Bruns; Michael G Kaul; Eric C Hansen; Mariya Barch; Agata Wiśniowska; Ou Chen; Yue Chen; Nan Li; Satoshi Okada; Jose M Cordero; Markus Heine; Christian T Farrar; Daniel M Montana; Gerhard Adam; Harald Ittrich; Alan Jasanoff; Peter Nielsen; Moungi G Bawendi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 2.  Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.

Authors:  Ching-Hui Huang; Andrew Tsourkas
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 3.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

Review 4.  Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Authors:  Forrest M Kievit; Miqin Zhang
Journal:  Adv Mater       Date:  2011-08-15       Impact factor: 30.849

5.  Multimodality and nanoparticles in medical imaging.

Authors:  Wen-Yen Huang; Jason J Davis
Journal:  Dalton Trans       Date:  2011-03-14       Impact factor: 4.390

6.  Sol and gel states in peptide hydrogels visualized by Gd(III)-enhanced magnetic resonance imaging.

Authors:  Mahika Weerasekare; Marc B Taraban; Xianfeng Shi; Eun-Kee Jeong; Jill Trewhella; Yihua Bruce Yu
Journal:  Biopolymers       Date:  2011-03-07       Impact factor: 2.505

7.  Magnetic and optical properties of multifunctional core-shell radioluminescence nanoparticles.

Authors:  Hongyu Chen; Daniel C Colvin; Bin Qi; Thomas Moore; Jian He; O Thompson Mefford; Frank Alexis; John C Gore; Jeffrey N Anker
Journal:  J Mater Chem       Date:  2012-07-07

8.  Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.

Authors:  Tatjana Paunesku; Tianyi Ke; Rohan Dharmakumar; Nicole Mascheri; Aiguo Wu; Barry Lai; Stefan Vogt; Jörg Maser; Kenneth Thurn; Barbara Szolc-Kowalska; Andrew Larson; Raymond C Bergan; Reed Omary; Debiao Li; Zheng-Rong Lu; Gayle E Woloschak
Journal:  Nanomedicine       Date:  2008-06-24       Impact factor: 5.307

9.  Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence.

Authors:  Hongyu Chen; Thomas Moore; Bin Qi; Daniel C Colvin; Erika K Jelen; Dale A Hitchcock; Jian He; O Thompson Mefford; John C Gore; Frank Alexis; Jeffrey N Anker
Journal:  ACS Nano       Date:  2013-01-09       Impact factor: 15.881

10.  Synthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging.

Authors:  Gholamreza Azizian; Nader Riyahi-Alam; Soheila Haghgoo; Hamid Reza Moghimi; Reza Zohdiaghdam; Behrooz Rafiei; Ensieh Gorji
Journal:  Nanoscale Res Lett       Date:  2012-10-03       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.